SCHEMBL23920870

SCHEMBL23920870

CCCSc1nc2c(=O)n3cc(-c4ccccc4)[nH]c3nc2n1CCO

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.52
ADORA1 P30542 2/20 0.52
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
TP53 P04637 1/20 0.38
APLNR P35414 1/20 0.37
POLB P06746 1/20 0.37
BRAF P15056 1/20 0.37
PIK3CG P48736 1/20 0.37
GAA P10253 1/20 0.36
DRD2 P14416 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920978 0.92 ADORA3 (0.52) ADORA3ADORA1ALDH1A1TSHRMAPK1
SCHEMBL23921155 0.91 ADORA3 (0.46) ADORA3ADORA1MEN1KMT2AALDH1A1
SCHEMBL23921143 0.91 ADORA3 (0.46) ADORA3ADORA1ALDH1A1TSHRMAPK1
SCHEMBL23920877 0.89 ADORA3 (0.49) ADORA3ADORA1MEN1KMT2AALDH1A1
SCHEMBL23921233 0.88 ADORA3 (0.51) ADORA3ADORA1MEN1KMT2ATDP1
SCHEMBL21396510 0.88 ADORA3 (0.46) ADORA3ADORA1ALDH1A1TDP1TP53
SCHEMBL23921219 0.86 ADORA3 (0.45) ADORA3ADORA1KMT2AALDH1A1TP53
SCHEMBL23920929 0.83 ADORA3 (0.46) ADORA3ADORA1MEN1KMT2AALDH1A1
SCHEMBL23920960 0.83 ADORA3 (0.44) ADORA3ADORA1ALDH1A1TSHRTDP1
SCHEMBL21396522 0.83 RXFP1 (0.47) ADORA3ADORA1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 ADORA3 425/4885ADORA1 857/4885MEN1 2620/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A ADORA3 449/4885ADORA1 828/4885MEN1 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.